Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults
Authors:
Open Access
- 22 June 2004
- journal article
- research article
- Published by Springer Nature in International Journal of Obesity
- Vol. 28 (8) , 998-1003
Abstract
OBJECTIVE: This study sought to determine the relationship between levels of the inflammatory marker, C-reactive protein (CRP), cardiovascular risk factors and oral contraceptive use in young adults. DESIGN: Cross-sectional study of a community cohort. SUBJECTS: A total of 822 men and women aged 26 y. MEASUREMENTS: CRP, body mass index (BMI), blood pressure, lipid and lipoprotein levels, smoking status, socioeconomic status, health status, and hormonal contraceptive use in women. RESULTS: Multiple regression analysis showed that obesity was independently related to CRP with an increase in ratio CRP of 1.03 (95% CI 1.01, 1.05) for men and 1.07 (1.05, 1.09) for women associated with a 1 kg/m2 increase in BMI. In women, combined oral contraceptive use was associated with a ratio change in CRP of 1.52 (1.27, 1.82) compared with nonusers. Other independent determinants of CRP in men and women were apolipoprotein B level, systolic blood pressure and apolipoprotein A1 in men. Univariate analysis showed that the relationship between CRP and BMI, systolic blood pressure and apolipoprotein B was significantly stronger in women than men. CONCLUSION: These findings suggest that obesity is associated with inflammation independent of other cardiovascular risk factors that may contribute to an increased risk for cardiovascular disease in men and women. Elevated CRP related to combined oral contraceptive use may influence the rate of cardiovascular events in young women.Keywords
This publication has 30 references indexed in Scilit:
- C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular EventsCirculation, 2003
- Inflammation and AtherosclerosisCirculation, 2002
- The relation of body fat mass and distribution to markers of chronic inflammationInternational Journal of Obesity, 2001
- Occlusive Vascular Diseases in Oral Contraceptive UsersDrugs, 2000
- C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial DysfunctionArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in menDiabetes Care, 1996
- Body weight and risk of myocardial infarction and death in the adult population of eastern Finland.BMJ, 1987
- Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.Circulation, 1983
- Relation of body weight to development of ischemic heart disease in a cohort of young north American men after a 26 year observation period: The manitoba studyThe American Journal of Cardiology, 1977
- Antinuclear Antibodies, Rheumatoid Factor and c‐Reactive Protein in Serum of Normal Women Using Oral ContraceptivesArthritis & Rheumatism, 1971